Active Specific Immunotherapy of Renal Cell Carcinoma: Cellular and Humoral Immune Responses

1997 ◽  
Vol 12 (3) ◽  
pp. 157-165 ◽  
Author(s):  
Ulrich Zorn ◽  
Stefan Duensing ◽  
Frauke Langkopf ◽  
Gerasimos Anastassiou ◽  
Hartmut Kirchner ◽  
...  
1978 ◽  
Vol 4 (4) ◽  
pp. 250-258 ◽  
Author(s):  
H. Tykkä ◽  
K.J. Oravisto ◽  
T. Lehtonen ◽  
S. Sarna ◽  
T. Tallberg

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Facundo Davaro ◽  
Elizabeth Davaro ◽  
Amna Qureshi ◽  
Lindsay Lombardo

Renal cell carcinoma (RCC) is associated with a variety of different histopathologic subtypes in which each subtype may be further subclassified. These entities carry with them unique prognoses and necessitate treatment with specific immunotherapy agents should advanced disease be uncovered. Meanwhile, aberrant physiologic processes may lead to unique histologic findings within these subtypes, further complicating management and prognostication. Heterotopic ossification within RCC is one of these rare occurrences and was once thought to have favorable prognostic implications. We report a case of a young female with papillary type 2 RCC with heterotopic ossification.


Sign in / Sign up

Export Citation Format

Share Document